PetMed Express Inc (PETS)
4.005
-0.12
(-3.03%)
USD |
NASDAQ |
Apr 25, 13:11
PetMed Express Enterprise Value: 37.91M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 24, 2024 | 37.91M |
April 23, 2024 | 38.34M |
April 22, 2024 | 36.22M |
April 19, 2024 | 37.49M |
April 18, 2024 | 37.49M |
April 17, 2024 | 39.82M |
April 16, 2024 | 38.76M |
April 15, 2024 | 37.49M |
April 12, 2024 | 38.60M |
April 11, 2024 | 38.17M |
April 10, 2024 | 41.14M |
April 09, 2024 | 44.73M |
April 08, 2024 | 48.54M |
April 05, 2024 | 47.27M |
April 04, 2024 | 51.08M |
April 03, 2024 | 51.29M |
April 02, 2024 | 51.29M |
April 01, 2024 | 49.60M |
March 28, 2024 | 51.93M |
March 27, 2024 | 52.99M |
March 26, 2024 | 53.62M |
March 25, 2024 | 51.29M |
March 22, 2024 | 50.02M |
March 21, 2024 | 51.08M |
March 20, 2024 | 52.78M |
Date | Value |
---|---|
March 19, 2024 | 51.08M |
March 18, 2024 | 51.29M |
March 15, 2024 | 53.20M |
March 14, 2024 | 51.08M |
March 13, 2024 | 51.08M |
March 12, 2024 | 53.83M |
March 11, 2024 | 59.34M |
March 08, 2024 | 56.80M |
March 07, 2024 | 56.58M |
March 06, 2024 | 55.74M |
March 05, 2024 | 58.70M |
March 04, 2024 | 59.12M |
March 01, 2024 | 56.58M |
February 29, 2024 | 57.64M |
February 28, 2024 | 57.43M |
February 27, 2024 | 59.76M |
February 26, 2024 | 58.91M |
February 23, 2024 | 62.30M |
February 22, 2024 | 59.55M |
February 21, 2024 | 59.12M |
February 20, 2024 | 60.39M |
February 16, 2024 | 60.82M |
February 15, 2024 | 63.14M |
February 14, 2024 | 62.30M |
February 13, 2024 | 63.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
36.22M
Minimum
Apr 22 2024
943.55M
Maximum
Jan 27 2021
368.81M
Average
364.61M
Median
Mar 18 2020
Enterprise Value Benchmarks
TruBridge Inc | 309.46M |
Streamline Health Solutions Inc | 27.33M |
R1 RCM Inc | 6.446B |
LifeMD Inc | 436.50M |
LENZ Therapeutics Inc | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.027M |
Revenue (Quarterly) | 65.32M |
Total Expenses (Quarterly) | 68.39M |
EPS Diluted (Quarterly) | -0.10 |
Gross Profit Margin (Quarterly) | 27.38% |
Profit Margin (Quarterly) | -3.10% |
Earnings Yield | -9.82% |
Normalized Earnings Yield | -9.824 |